Disparities in Cardiovascular Research Output and Disease Outcomes among High-, Middle- and Low-Income Countries – An Analysis of Global Cardiovascular Publications over the Last Decade (2008–2017)
References
- World Health Organization.
Global status report on noncommunicable diseases 2014 . World Health Organization, 2014. - Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100): 1151–210. DOI: 10.1016/S0140-6736(17)32152-9
- Frumkin H, Haines A. Global Environmental Change and Noncommunicable Disease Risks. Annual Review of Public Health. 2019; 40(1): 261–82. DOI: 10.1146/annurev-publhealth-040218-043706
- World Health Organization. Noncommunicable diseases country profiles 2014. 2014.
- Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017; 390(10100): 1211–59. DOI: 10.1016/S0140-6736(17)32154-2
- World Health Organization. The top 10 causes of death 2018. Retreived from:
https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death . - Miranda JJ, Kinra S, Casas JP, Davey Smith G, Ebrahim S. Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Tropical Medicine & International Health. 2008; 13(10): 1225–34. DOI: 10.1111/j.1365-3156.2008.02116.x
- Reducing The Growing Burden Of Cardiovascular Disease In The Developing World. Health Affairs. 2007; 26(1): 13–24. DOI: 10.1377/hlthaff.26.1.13
- World Health Organization.
A comprehensive global monitoring framework including indicators and a set of voluntary global targets for the prevention and control of noncommunicable diseases . Geneva: World Health Organization. 2012. - Anderson GF, Chu E. Expanding Priorities — Confronting Chronic Disease in Countries with Low Income. New England Journal of Medicine. 2007; 356(3): 209–11. DOI: 10.1056/NEJMp068182
- Bennett JE, Stevens GA, Mathers CD, Bonita R, Rehm J, Kruk ME, et al. NCD Countdown 2030: Worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. The Lancet. 2018; 392(10152): 1072–88. DOI: 10.1016/S0140-6736(18)31992-5
- Murray CJL, Lopez, Alan D, World Health Organization, World Bank & Harvard School of Public Health. The Global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. 1996.
- Huffman MD, Baldridge A, Bloomfield GS, Colantonio LD, Prabhakaran P, Ajay VS, et al. Global Cardiovascular Research Output, Citations, and Collaborations: A Time-Trend, Bibliometric Analysis (1999–2008). PLOS ONE. 2014; 8(12):
e83440 . DOI: 10.1371/journal.pone.0083440 - Research GFfH, (Ed.).
The 10/90 Report on Health Research2001 : Global Forum for Health Research. - Lloyd-Sherlock P, Ebrahim S, Martinez R, McKee M, Ordunez P. Reducing the cardiovascular disease burden for people of all ages in the Americas region: Analysis of mortality data, 2000–15. The Lancet Global Health. 2019; 7(5): e604–e12. DOI: 10.1016/S2214-109X(19)30069-5
- Kahn R, Robertson RM, Smith R, Eddy D. The Impact of Prevention on Reducing the Burden of Cardiovascular Disease. Circulation. 2008; 118(5): 576–85. DOI: 10.1161/CIRCULATIONAHA.108.190186
- Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): A prospective epidemiological survey. The Lancet. 2011; 378(9798): 1231–43. DOI: 10.1016/S0140-6736(11)61215-4
- Vidyasagar D. Global notes: The 10/90 gap disparities in global health research. Journal Of Perinatology. 2005; 26: 55. DOI: 10.1038/sj.jp.7211402
- Jahangir E, Comandé D, Rubinstein A. Cardiovascular disease research in Latin America: A comparative bibliometric analysis. World Journal of Cardiology. 2011; 3(12): 383–7. DOI: 10.4330/wjc.v3.i12.383
- Khachfe HH, Refaat MM. Bibliometric analysis of Cardiovascular Disease Research Activity in the Arab World. 2019; 15. DOI: 10.17987/icfj.v15i0.554
- Saquib N, Zaghloul MS, Mazrou A, Saquib J. Cardiovascular disease research in Saudi Arabia: A bibliometric analysis. Scientometrics. 2017; 112(1): 111–40. DOI: 10.1007/s11192-017-2393-z
- Al-Kindi S, Al-Juhaishi T, Haddad F, Taheri S, Abi Khalil C. Cardiovascular disease research activity in the Middle East: A bibliometric analysis. Therapeutic Advances in Cardiovascular Disease. 2015; 9(3): 70–6. DOI: 10.1177/1753944715578585
- Bloomfield Gerald S, Baldridge A, Agarwal A, Huffman Mark D, Colantonio Lisandro D, Bahiru E, et al. Disparities in Cardiovascular Research Output and Citations From 52 African Countries: A Time-Trend, Bibliometric Analysis (1999–2008). Journal of the American Heart Association. 4(4):
e001606 . DOI: 10.1161/JAHA.114.001606 - Yu Q, Shao H, He P, Duan Z. World scientific collaboration in coronary heart disease research. International Journal of Cardiology. 2013; 167(3): 631–9. DOI: 10.1016/j.ijcard.2012.09.134
- Prabhakaran P, Ajay VS, Prabhakaran D, Gottumukkala AK, Shrihari JS, Snehi U, et al. Global Cardiovascular Disease Research Survey. Journal of the American College of Cardiology. 2007; 50(24): 2322–8. DOI: 10.1016/j.jacc.2007.08.040
- Mendis S, Yach D, Bengoa R, Narvaez D, Zhang X. Research gap in cardiovascular disease in developing countries. The Lancet. 2003; 361(9376): 2246–7. DOI: 10.1016/S0140-6736(03)13753-1
- Gal D, Glänzel W, Sipido KR. Mapping cross-border collaboration and communication in cardiovascular research from 1992 to 2012. Eur Heart J. 2017; 38(16): 1249–58. DOI: 10.1093/eurheartj/ehw459
- Lewison G, Purushotham A, Mason M, McVie G, Sullivan R. Understanding the impact of public policy on cancer research: A bibliometric approach. Eur J Cancer. 2010; 46(5): 912–9. DOI: 10.1016/j.ejca.2009.12.020
- Yin L, Wu Q, Hong D. Statistical Methods and Software Package for Medical Trend Analysis in Health Rate Review Process. J Health Med Inform. 2016; 7(219).
- OA K. Selection of the Forecasting Model in Health Care. J Hosp Med Manage. 2016; 2(2).
- Soyiri IN, Reidpath DD. An overview of health forecasting. Environ Health Prev Med. 2013; 18(1): 1–9. DOI: 10.1007/s12199-012-0294-6
- Calegari R, Fogliatto FS, Lucini FR, Neyeloff J, Kuchenbecker RS, Schaan BD. Forecasting Daily Volume and Acuity of Patients in the Emergency Department. Comput Math Methods Med. 2016; 2016: 3863268. DOI: 10.1155/2016/3863268
- Ordu M, Demir E, Tofallis C. A comprehensive modelling framework to forecast the demand for all hospital services. The International Journal of Health Planning and Management. 2019; 34(2): e1257–e71. DOI: 10.1002/hpm.2771
- Kalekar PS. Time series forecasting using holt-winters exponential smoothing. Kanwal Rekhi School of Information Technology. 2004; 4329008(13).
- Gardner ES, McKenzie E. Forecasting Trends in Time Series. Management Science. 1985; 31(10): 1237–46. DOI: 10.1287/mnsc.31.10.1237
- Pegels CC. Exponential Forecasting: Some New Variations. Management Science. 1969; 15(5): 311–5. DOI: 10.1287/mnsc.15.5.311
- Dye C, Reeder JC, Terry RF. Research for universal health coverage. American Association for the Advancement of Science; 2013.
- Chen L, Evans T, Anand S, Boufford JI, Brown H, Chowdhury M, et al. Human resources for health: overcoming the crisis. The Lancet. 2004; 364(9449): 1984–90. DOI: 10.1016/S0140-6736(04)17482-5
- Evans JR, Hall KL, Warford J. Health care in the developing world: Problems of scarcity and choice (Shattuck lecture). Population. 1981; 61: 74.
- Kassebaum NJ, Arora M, Barber RM, Bhutta ZA, Brown J, Carter A, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016; 388(10053): 1603–58. DOI: 10.1016/S0140-6736(16)31460-X
- Varmus H.
The art and politics of science . WW Norton & Company; 2009. - Fuster V. Dilemmas of NIH Funding for Cardiovascular Research. Circulation. 1998; 98(13): 1253–4. DOI: 10.1161/01.CIR.98.13.1253
- Bitton A, Gaziano T. The Framingham Heart Study’s Impact on Global Risk Assessment. Progress in Cardiovascular Diseases. 2010; 53(1): 68–78. DOI: 10.1016/j.pcad.2010.04.001
- Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: A historical perspective. The Lancet. 2014; 383(9921): 999–1008. DOI: 10.1016/S0140-6736(13)61752-3
- Oppenheimer GM. Becoming the Framingham Study 1947–1950. American Journal of Public Health. 2005; 95(4): 602–10. DOI: 10.2105/AJPH.2003.026419
- Starfield B. Is US Health Really the Best in the World? JAMA. 2000; 284(4): 483–5. DOI: 10.1001/jama.284.4.483
- Kim K, Johnson JA, Derendorf H. Differences in Drug Pharmacokinetics Between East Asians and Caucasians and the Role of Genetic Polymorphisms. The Journal of Clinical Pharmacology. 2004; 44(10): 1083–105. DOI: 10.1177/0091270004268128
- Bertilsson L. Geographical/Interracial Differences in Polymorphic Drug Oxidation. Clinical Pharmacokinetics. 1995; 29(3): 192–209. DOI: 10.2165/00003088-199529030-00005
- Bradford LD. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics. 2002; 3(2): 229–43. DOI: 10.1517/14622416.3.2.229
- Takahashi H, Kashima T, Nomizo Y, Muramoto N, Shimizu T, Nasu K, et al. Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes. Clinical Pharmacology & Therapeutics. 1998; 63(5): 519–28. DOI: 10.1016/S0009-9236(98)90103-5
- Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): A prospective epidemiological survey. The Lancet. 2011; 378(9798): 1231–43. DOI: 10.1016/S0140-6736(11)61215-4
- World Health Organization. A prioritized research agenda for prevention and control of noncommunicable diseases. 2011.
- Institute for Health Metrics and Evaluation. High burden, low budget: Non-communicable diseases in low- and middle-income countries 2018. Retrieved from:
http://www.healthdata.org/infographic/high-burden-low-budget-non-communicable-diseases-low-and-middle-income-countries . - Anderson GF, Chu E. Expanding priorities–confronting chronic disease in countries with low income. N Engl J Med. 2007; 356(3): 209–11. DOI: 10.1056/NEJMp068182
- Islam SMS, Purnat TD, Phuong NTA, Mwingira U, Schacht K, Fröschl G. Non-Communicable Diseases (NCDs) in developing countries: A symposium report. Globalization and health. 2014; 10(1): 81. DOI: 10.1186/s12992-014-0081-9
- Beaglehole R, Yach D. Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults. The Lancet. 2003; 362(9387): 903–8. DOI: 10.1016/S0140-6736(03)14335-8
DOI: https://doi.org/10.5334/gh.815 | Journal eISSN: 2211-8179
Language: English
Submitted on: Apr 26, 2020
Accepted on: Dec 8, 2020
Published on: Jan 18, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2021 Nada Qaisar Qureshi, Syed Hamza Mufarrih, Gerald S. Bloomfield, Wajeeha Tariq, Aysha Almas, Ali H. Mokdad, John Bartlett, Imran Nisar, Sameen Siddiqi, Zulfiqar Bhutta, Daniel Mark, Pamela S. Douglas, Zainab Samad, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.